Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04142281 · ClinicalTrials.gov registry record
ILSI Energy Balance Study
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 24
- Enrollment target
NCT04142281: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT04142281 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04142281 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to apply measurement error techniques on consumer devices to assess rate of energy storage \[ES\] and energy expenditure \[EE\], then estimate EI using the intake-balance technique. The goal of this study is to develop calibration models that will be able to be translated to other consumer devices with only minor modifications given common hardware (e.g. triaxial accelerometry), resulting in overall improved ability to assess energy balance and EI at a population level and positive health outcomes.
Primary Outcome
Energy intake will be assessed subjectively via interviewer-administered dietary recalls. Three dietary recalls will occur on randomly selected non-consecutive days over each one-week treatment condition (including at least one weekend day) to minimize preparation that could bias recall by the participants. All interviews will be conducted over the telephone, will ask about all foods consumed over the previous 24 hours using a multi-pass approach, and energy intake will be calculated using the N
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-01-13 |
| Est. Completion | 2018-07-05 |
What the finished NCT04142281 record still lists
NCT04142281 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04142281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04142281 about?
NCT04142281 is a clinical study titled "ILSI Energy Balance Study". The purpose of this study is to apply measurement error techniques on consumer devices to assess rate of energy storage \[ES\] and energy expenditure \[EE\], then estimate EI using the intake-balance technique. The goal of this study is to develop calibration models that will be able to be translat...
What is the current status of trial NCT04142281?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-01-13. Estimated completion is 2018-07-05.
Who is sponsoring clinical trial NCT04142281?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI